Ingredion Incorporated (INGR)

NYQ – Real Time Price. Currency in USD

103.51

-1.16 (-1.11%)

Market open: Aug 12, 2026, 11:35 AM EDT

104.94

+0.27 (0.26%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

05.08.2026

Ingredion Q2 Earnings Beat Estimates on T&HS Volume Growth

Ingredion beats Q2 estimates as 7% Texture & Healthful Solutions volume growth and FX gains offset Argo issues and higher costs.

05.08.2026

Ingredion Q2 Earnings Call Highlights

Ingredion NYSE: INGR reported second-quarter 2026 results that were in line with its expectations, as continued growth in Texture & Healthful Solutions offset operational and macroeconomic pressures in other parts of the portfolio.

04.08.2026

Ingredion Incorporated (INGR) Q2 2026 Earnings Call Transcript

04.08.2026

Ingredion (INGR) Q2 Earnings and Revenues Beat Estimates

Ingredion (INGR) came out with quarterly earnings of $2.82 per share, beating the Zacks Consensus Estimate of $2.73 per share. This compares to earnings of $2.87 per share a year ago.

04.08.2026

Ingredion Incorporated Reports Second Quarter 2026 Results

Second quarter 2026 reported and adjusted* operating income decreased 31% and 5% compared to the second quarter 2025 Second quarter 2026 reported and adjusted EPS were $1.78 and $2.82, compared with $2.99 and $2.87 in the second quarter 2025 Reaffirming amended full-year guidance, which now reflects the sale of a majority stake in the Pakistan business, for reported EPS to be in the range of $9.15 to $9.75 and adjusted EPS to be in the range of $10.30 to $10.90 Ingredion's 595 pence all-cash offer to acquire Tate & Lyle accepted by their shareholders WESTCHESTER, Ill., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, today reported its second quarter 2026 results.

03.08.2026

Is Ingredion Stock a Buy as Cheap Valuation Meets Execution Risk?

Ingredion's cheap valuation and growing specialty business support the bull case, but Argo execution risks and weaker guidance argue for patience.

03.08.2026

How Ingredion's Tate & Lyle Deal Could Reshape Its Growth Outlook

Ingredion's proposed $5 billion Tate & Lyle deal could expand its specialty platform and global reach, but approvals and integration risks remain.

Videos

No Data

There is no data to display

Press releases

04.08.2026

Ingredion Incorporated (INGR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Ingredion Incorporated (INGR)

Ingredion Q2 Earnings Beat Estimates on T&HS Volume Growth

Ingredion Q2 Earnings Call Highlights

Ingredion Incorporated (INGR) Q2 2026 Earnings Call Transcript

Ingredion (INGR) Q2 Earnings and Revenues Beat Estimates

Ingredion Incorporated Reports Second Quarter 2026 Results

Is Ingredion Stock a Buy as Cheap Valuation Meets Execution Risk?

How Ingredion's Tate & Lyle Deal Could Reshape Its Growth Outlook

Videos

No Data

Press releases

Ingredion Incorporated Reports Second Quarter 2026 Results

Ingredion Q2 Earnings Beat Estimates on T&HS Volume Growth

Ingredion Q2 Earnings Call Highlights

Ingredion Incorporated (INGR) Q2 2026 Earnings Call Transcript

Ingredion (INGR) Q2 Earnings and Revenues Beat Estimates

Ingredion Incorporated Reports Second Quarter 2026 Results

Is Ingredion Stock a Buy as Cheap Valuation Meets Execution Risk?

How Ingredion's Tate & Lyle Deal Could Reshape Its Growth Outlook

Videos

No Data

Press releases

Ingredion Incorporated Reports Second Quarter 2026 Results

Search stocks

Ingredion Incorporated (INGR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Ingredion Incorporated (INGR)

Ingredion Q2 Earnings Beat Estimates on T&HS Volume Growth

Ingredion Q2 Earnings Call Highlights

Ingredion Incorporated (INGR) Q2 2026 Earnings Call Transcript

Ingredion (INGR) Q2 Earnings and Revenues Beat Estimates

Ingredion Incorporated Reports Second Quarter 2026 Results

Is Ingredion Stock a Buy as Cheap Valuation Meets Execution Risk?

How Ingredion's Tate & Lyle Deal Could Reshape Its Growth Outlook

Videos

No Data

Press releases

Ingredion Incorporated Reports Second Quarter 2026 Results

Ingredion Q2 Earnings Beat Estimates on T&HS Volume Growth

Ingredion Q2 Earnings Call Highlights

Ingredion Incorporated (INGR) Q2 2026 Earnings Call Transcript

Ingredion (INGR) Q2 Earnings and Revenues Beat Estimates

Ingredion Incorporated Reports Second Quarter 2026 Results

Is Ingredion Stock a Buy as Cheap Valuation Meets Execution Risk?

How Ingredion's Tate & Lyle Deal Could Reshape Its Growth Outlook

Videos

No Data

Press releases

Ingredion Incorporated Reports Second Quarter 2026 Results